mRESVIA
- Licence status
- Active substances
- Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation
- Dosage Form
- Dispersion for injection
- Licence number
- EU/1/24/1849/001-002
- Licence holder
- Moderna Biotech Spain S.L.
Product documents
Licence information
- ATC code
- J07BX05 respiratory syncytial virus vaccines
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to medical prescription. • Official batch release In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 22/08/2024